The first bellwether trial in the C.R. Bard multidistrict litigation in a West Virginia federal court has come to a sudden halt following a mistrial ruling. U.S. District Judge Joseph R. Goodwin ruled in favor of a mistrial following an overly revealing statement made by a gynecologist acting as an expert witness for the plaintiff in the case.
With the revelation that C.R. Bard pulled their Avaulta transvaginal mesh products from the market in 2012, C. R. Bard’s lawyers and Judge Goodwin conceded that the trial could no longer be deemed fair. In a Bloomberg article on the C. R. Bard mistrial, Judge Goodwin went on to state that he considered the gynecologist’s statement to be something that could not be ignored by the jury in the case.
As of July 11, 2013, there are approximately 3,910 transvaginal mesh lawsuits that have been consolidated into the C.R. Bard MDL in West Virginia. Plaintiffs have filed their transvaginal mesh lawsuits alleging that C.R. Bard’s Avaulta transvaginal mesh products cause serious internal injuries following implantation.
C.R. Bard is not the only transvaginal mesh manufacturer facing thousands of transvaginal mesh lawsuits in the West Virginia federal court. Plaintiffs who claim to have been injured following transvaginal mesh implantation surgery have filed lawsuits against American Medical Systems, Boston Scientific Corp., Ethicon, Coloplast Corp., and Cook Medical. Judge Goodwin is presiding over each of these transvaginal mesh MDLs in the U.S. District Court for the Southern District of West Virginia.
Though the news of the mistrial is an unexpected outcome, Carey Danis & Lowe transvaginal mesh lawyers want to inform individuals who believe that they have been injured by a transvaginal mesh product to still seek legal advice.
Carey Danis & Lowe encourages those who claim injury from transvaginal mesh to explore our transvaginal mesh information page. Once there, visitors can learn more about eligibility and receive assistance in filing a transvaginal mesh lawsuit.